These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33124149)

  • 21. COVID-19 and Crosstalk With the Hallmarks of Aging.
    Salimi S; Hamlyn JM
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e34-e41. PubMed ID: 32544216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
    Singh KK; Chaubey G; Chen JY; Suravajhala P
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of dysregulated immune responses in COVID-19 pathogenesis.
    Tahaghoghi-Hajghorbani S; Zafari P; Masoumi E; Rajabinejad M; Jafari-Shakib R; Hasani B; Rafiei A
    Virus Res; 2020 Dec; 290():198197. PubMed ID: 33069815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peripheral and core regions of virus-host network of COVID-19.
    Wang B; Dong X; Hu J; Ma X; Han C; Wang Y; Gao L
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33956950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro.
    Fan H; Hong B; Luo Y; Peng Q; Wang L; Jin X; Chen Y; Hu Y; Shi Y; Li T; Zhuang H; Zhou YH; Tong Y; Xiang K
    Signal Transduct Target Ther; 2020 Nov; 5(1):275. PubMed ID: 33235188
    [No Abstract]   [Full Text] [Related]  

  • 26. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.
    Wang Y; Zhu X; Jiang XM; Guo J; Fu Z; Zhou Z; Yang P; Guo H; Guo X; Liang G; Zeng P; Xiao G; Ma J; Yin X; Zhang LK; Yan C; Zhang CY
    Signal Transduct Target Ther; 2021 Aug; 6(1):300. PubMed ID: 34381015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
    Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
    Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic factors associated with increased severity of Covid-19.
    Yildirim Z; Sahin OS; Yazar S; Bozok Cetintas V
    Cell Biol Int; 2021 Jun; 45(6):1158-1174. PubMed ID: 33590936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.
    Dastar S; Gharesouran J; Mortazavi D; Hosseinzadeh H; Kian SJ; Taheri M; Ghafouri-Fard S; Jamali E; Rezazadeh M
    Hum Antibodies; 2022; 30(1):1-14. PubMed ID: 34864654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
    Butler D; Mozsary C; Meydan C; Foox J; Rosiene J; Shaiber A; Danko D; Afshinnekoo E; MacKay M; Sedlazeck FJ; Ivanov NA; Sierra M; Pohle D; Zietz M; Gisladottir U; Ramlall V; Sholle ET; Schenck EJ; Westover CD; Hassan C; Ryon K; Young B; Bhattacharya C; Ng DL; Granados AC; Santos YA; Servellita V; Federman S; Ruggiero P; Fungtammasan A; Chin CS; Pearson NM; Langhorst BW; Tanner NA; Kim Y; Reeves JW; Hether TD; Warren SE; Bailey M; Gawrys J; Meleshko D; Xu D; Couto-Rodriguez M; Nagy-Szakal D; Barrows J; Wells H; O'Hara NB; Rosenfeld JA; Chen Y; Steel PAD; Shemesh AJ; Xiang J; Thierry-Mieg J; Thierry-Mieg D; Iftner A; Bezdan D; Sanchez E; Campion TR; Sipley J; Cong L; Craney A; Velu P; Melnick AM; Shapira S; Hajirasouliha I; Borczuk A; Iftner T; Salvatore M; Loda M; Westblade LF; Cushing M; Wu S; Levy S; Chiu C; Schwartz RE; Tatonetti N; Rennert H; Imielinski M; Mason CE
    Nat Commun; 2021 Mar; 12(1):1660. PubMed ID: 33712587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
    Yasmin H; Saha S; Butt MT; Modi RK; George AJT; Kishore U
    Adv Exp Med Biol; 2021; 1313():99-134. PubMed ID: 34661893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
    Wong NA; Saier MH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.
    Huang X; Zhang C; Pearce R; Omenn GS; Zhang Y
    J Proteome Res; 2020 Dec; 19(12):4844-4856. PubMed ID: 33175551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.
    Zepeda-Cervantes J; Martínez-Flores D; Ramírez-Jarquín JO; Tecalco-Cruz ÁC; Alavez-Pérez NS; Vaca L; Sarmiento-Silva RE
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.
    Goodnow CC
    Immunol Cell Biol; 2021 Feb; 99(2):177-191. PubMed ID: 33113212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.